Lowey Dannenberg Notifies TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against TransMedics Group, Inc. for violations of federal securities laws, impacting investors who purchased shares during the specified Class Period [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that TransMedics and its officers made false or misleading statements and failed to disclose critical information regarding the company's business practices [2]. - Specific allegations include the use of kickbacks, fraudulent overbilling, and coercive tactics to generate revenue, as well as unsafe practices and lack of safety oversight [2]. Group 2: Impact on Investors - Following the revelation of these issues, TransMedics' stock experienced a significant decline, resulting in financial losses for investors [3]. - Investors who suffered losses exceeding $100,000 are encouraged to participate in the lawsuit, with a deadline to act by April 15, 2025 [3]. Group 3: About the Law Firm - Lowey Dannenberg P.C. specializes in representing investors who have suffered financial losses due to corporate fraud and has a history of recovering billions for clients [4].